What if existing medicines could help treat diseases with limited treatment options? Advances in artificial intelligence are helping researchers explore that possibility, opening new doors for rare disease research and innovation.
In this episode of Heart to Heart, we examine how artificial intelligence and drug repurposing are being used to identify potential new treatments for rare diseases. Through the work of Dr. David Fajgenbaum and the Every Cure initiative, we explore how existing medications may be studied for new therapeutic uses, potentially reducing the time and cost of traditional drug development.
The episode also considers what these emerging approaches could mean for Kawasaki disease research. While many questions remain, new technologies and strategies could accelerate discoveries and improve understanding and treatment of complex conditions. We discuss why continued investment in research, patient advocacy, and public awareness remain essential. Progress depends not only on science but also on voices of patients, families, clinicians, and advocates pushing for answers.
Whether you’re affected by Kawasaki disease, a healthcare professional, or interested in medical research’s future, this episode offers a clear look at how AI is transforming treatment discovery.